Seattle, Washington-based Accolade Inc. is scheduled to list its IPO on the Nasdaq Global Select Market under the symbol "ACCD" on July 2, 2020. The initial public offering price is expected to be between $19.00 and $21.00 per share.
from RTT - Biotech https://ift.tt/31ujEM1
via IFTTT
No comments:
Post a Comment